CASe STUDY: DHNY SUMMIT DRIVES MEANINGFUL PARTNERSHIPS

Overview: DHNY Summit connects senior leaders to accelerate innovation resulting in tangible business outcomes. A compelling example from DHNY Summit 2025 shows how one conversation evolved into a strategic partnership between two innovative healthcare companies.

Leo Grady
Founder & CEO
Jona

Julia Cheek
Founder & CEO
Everlywell

“DHNY Summit creates the kind of environment where meaningful partnerships actually happen. Our connection with Everlywell has the potential to significantly expand access to personalized microbiome insights.”

— Leo Grady, Founder & CEO, Jona

“The Summit brings together the right mix of innovators and operators, and meeting Jona at DHNY is a perfect example of why. We’ve spent the last decade giving people real answers about their health from home, and gut microbiome is one of the key frontiers ahead. Jona is the most advanced test in the space, pairing scientific rigor with proprietary AI to deliver actionable guidance. It’s exactly the kind of partnership we look for.”

— Julia Cheek, Founder & CEO, Everlywell

The Opportunity:

Leo Grady and Julia Cheek met at DHNY Summit. What began as an informal conversation quickly evolved into deeper discussions around shared vision to go beyond surface-level answers and give people real, actionable guidance to feel better.

The Outcome:

As a direct result of their connection at DHNY Summit:

  • Jona and Everlywell entered into a strategic partnership to bring next-generation gut microbiome testing nationwide.

  • Everlywell deployed Jona’s AI-powered gut microbiome test across its established diagnostic platform.

  • This partnership expands access to the most advanced microbiome test on the market, powered by deep shotgun metagenomic sequencing and Jona's proprietary AI.

  • The companies plan to continue growing the partnership and empowering even more people with life-changing health insights and root-cause solutions.

Why It Matters:

This collaboration represents:

  • Accelerated innovation through shared vision and complementary capabilities.

  • Expanded market reach for an emerging digital health company.

  • Enhanced product offerings for an established diagnostics platform.

  • Improved consumer access to one of the most consequential frontiers in health: the gut microbiome's influence on digestion, immunity, metabolism, and beyond.

DHNY Summit is intentionally designed to bring together decision-makers across the healthcare ecosystem, facilitate curated, high-impact introductions, and create an environment where partnerships can take shape and scale. The collaboration between Jona and Everlywell exemplifies this approach in action, demonstrating how connections made at the Summit translate into meaningful commercial outcomes that help advance the future of healthcare.

About Jona

Jona is a clinical-grade microbiome analysis that goes beyond measurement to provide precision health insights. Using deep shotgun metagenomic sequencing and Jona AI, an advanced engine trained on more than 220,000 peer-reviewed studies, we analyze the gut microbiome at strain-level resolution to surface clinically relevant patterns. Our proprietary digital twin models how targeted diet, probiotic, and lifestyle interventions will shift an individual’s microbiome, turning complex data into clear, personalized Action Plans that clinicians can confidently use to drive outcomes. Learn more at jona.health.

About Everlywell

Everlywell is a digital health company pioneering the next generation of biomarker intelligence — combining AI-powered technology with human insight to deliver personalized, actionable health answers. In 2025, an estimated 1 in 94 U.S. adults received an Everlywell test, solidifying its spot as the #1 at-home lab testing company in the country. Fueled by AI and built for scale, Everlywell is breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. Learn more at everlywell.com.